Loading data for PRCT — first visit, this takes a few seconds.
PROCEPT BioRobotics Corporation
20.38 +0.31 (1.54%)
- Capitalización de mercado
- $1.16B
- Volumen
- 1.57M
- Próxima fecha de resultados
- Nov 4, 2026
PROCEPT BioRobotics Corporation (PRCT): cotización, análisis y datos
Valor intrínseco
Pronóstico del analista
Previsiones bursátiles →Últimos resultados
| Reportado | Vs. estimación | Cambio interanual | |
|---|---|---|---|
| Ingresos | $94.50M | n/a | +19.34% |
| EPS | -$0,47 | -$0,02 | -34.29% |
Métricas
- Precio de compra
- 13.9
- Ingresos (TTM)
- 337M
- Beneficio neto (TTM)
- -110M
- 0.90
- -1.95
- n/a
- -17.68
- P/B (TTM)
- 3.43
- P/S (TTM)
- 3.46
- Fecha de resultados
- Nov 4, 2026
- Precio de venta
- 22.04
- Volumen
- 1,573,244
- Volumen medio (20D)
- 1,582,977
- Abierto
- 20.53
- Anterior Cerrar
- 20.07
- Rango del día
- 19.55 - 20.67
- Rango de 52 semanas
- 16.66 - 40.10
- analista
- n/a
- Precio objetivo
- n/a
- Dividendos
- n/a
- Fecha ex dividendo
- n/a
Acerca de PROCEPT BioRobotics Corporation
Ver perfil →PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Industria Medical Devices
Sector Healthcare
IPO Fecha Sep 15, 2021
Empleados 888
Bolsa de Valores NasdaqGM
Símbolo bursátil PRCT
Sitio web https://www.procept-biorobotics.com